205 related articles for article (PubMed ID: 7729638)
1. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection.
Marinos G; Naoumov NV; Rossol S; Torre F; Wong PY; Gallati H; Portmann B; Williams R
Gastroenterology; 1995 May; 108(5):1453-63. PubMed ID: 7729638
[TBL] [Abstract][Full Text] [Related]
2. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.
Kallinowski B; Haseroth K; Marinos G; Hanck C; Stremmel W; Theilmann L; Singer MV; Rossol S
Clin Exp Immunol; 1998 Feb; 111(2):269-77. PubMed ID: 9486392
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection.
Marinos G; Torre F; Günther S; Thomas MG; Will H; Williams R; Naoumov NV
Gastroenterology; 1996 Jul; 111(1):183-92. PubMed ID: 8698197
[TBL] [Abstract][Full Text] [Related]
4. Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection.
Hussain MJ; Lau JY; Williams R; Vergani D
J Clin Pathol; 1994 Dec; 47(12):1112-5. PubMed ID: 7876386
[TBL] [Abstract][Full Text] [Related]
5. Serum levels and in situ expression of TNF-alpha and TNF-alpha binding proteins in inflammatory liver diseases.
Spengler U; Zachoval R; Gallati H; Jung MC; Hoffmann R; Riethmüller G; Pape G
Cytokine; 1996 Nov; 8(11):864-72. PubMed ID: 9047083
[TBL] [Abstract][Full Text] [Related]
6. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity.
Zylberberg H; Rimaniol AC; Pol S; Masson A; De Groote D; Berthelot P; Bach JF; Bréchot C; Zavala F
J Hepatol; 1999 Feb; 30(2):185-91. PubMed ID: 10068094
[TBL] [Abstract][Full Text] [Related]
7. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a long-term follow-up study.
Coppens JP; Cornu C; Lens E; Lamy M; Geubel AP
J Hepatol; 1990; 11 Suppl 1():S126-8. PubMed ID: 2079569
[TBL] [Abstract][Full Text] [Related]
8. Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection.
Fang JW; Shen WW; Meager A; Lau JY
Am J Gastroenterol; 1996 Apr; 91(4):748-53. PubMed ID: 8677942
[TBL] [Abstract][Full Text] [Related]
9. Histologic changes in Chinese patients with chronic hepatitis B virus infection after interferon-alpha therapy.
Wu PC; Lok AS; Lau JY; Lauder IJ; Lai CL
Am J Clin Pathol; 1992 Oct; 98(4):402-7. PubMed ID: 1415022
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection.
Marinos G; Smith HM; Naoumov NV; Williams R
Hepatology; 1994 Feb; 19(2):303-11. PubMed ID: 8294088
[TBL] [Abstract][Full Text] [Related]
11. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.
Lisker-Melman M; Webb D; Di Bisceglie AM; Kassianides C; Martin P; Rustgi V; Waggoner JG; Park Y; Hoofnagle JH
Ann Intern Med; 1989 Sep; 111(6):479-83. PubMed ID: 2774373
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C.
Fabris C; Del Forno M; Falleti E; Toniutto P; Pirisi M
Clin Exp Immunol; 1999 Sep; 117(3):556-60. PubMed ID: 10469062
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
[TBL] [Abstract][Full Text] [Related]
14. Interferon alfa-2b therapy in children with chronic hepatitis B.
Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
[TBL] [Abstract][Full Text] [Related]
15. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.
Hestdal K; Aukrust P; Müller F; Lien E; Bjerkeli V; Espevik T; Frøland SS
Blood; 1997 Oct; 90(7):2670-9. PubMed ID: 9326234
[TBL] [Abstract][Full Text] [Related]
17. Modulation of tumor necrosis factor receptors 1 and 2 in chronic hepatitis B and C: the differences and implications in pathogenesis.
Tai DI; Tsai SL; Chen TC; Lo SK; Chang YH; Liaw YF
J Biomed Sci; 2001; 8(4):321-7. PubMed ID: 11455194
[TBL] [Abstract][Full Text] [Related]
18. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1--relevance for concanavalin A-induced hepatitis.
Wolf D; Hallmann R; Sass G; Sixt M; Küsters S; Fregien B; Trautwein C; Tiegs G
J Immunol; 2001 Jan; 166(2):1300-7. PubMed ID: 11145713
[TBL] [Abstract][Full Text] [Related]
20. Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection.
Sheron N; Lau J; Daniels H; Goka J; Eddleston A; Alexander GJ; Williams R
J Hepatol; 1991 Mar; 12(2):241-5. PubMed ID: 2051003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
